找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cardiac Drug Development Guide; Michael K. Pugsley Book 2003 Springer Science+Business Media New York 2003

[復(fù)制鏈接]
查看: 9170|回復(fù): 45
樓主
發(fā)表于 2025-3-21 16:12:02 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Cardiac Drug Development Guide
編輯Michael K. Pugsley
視頻videohttp://file.papertrans.cn/222/221754/221754.mp4
概述Includes supplementary material:
叢書名稱Methods in Pharmacology and Toxicology
圖書封面Titlebook: Cardiac Drug Development Guide;  Michael K. Pugsley Book 2003 Springer Science+Business Media New York 2003
描述Cardiac Drug Development Guide outlines, in detail, the therapeutics of cardiac medicine currently at the cutting edge of scientific research and development around the world. This volume integrates basic and clinical cardiac pharmacology by c- bining, for the first time, both classical and molecular aspects of therapeutic drug development. The chapters comprise a broad spectrum of therapeutic areas and hence involve a comprehensive discussion of molecular, biochemical, and electrophy- ological concepts based on years of in vitro as well as in vivo pharmacological st- ies. In addition, the latter part of the book includes comprehensive clinical cardiac chapters that describe important topics in molecular medicine. These chapters also discuss current clinical therapeutic trends in medicine and provide an evaluation of the efficacy of novel drugs in these areas. Cardiac Drug Development Guide has many distinctive and outstanding features that set it apart from other cardiac pharmacology books. This book introduces topics in an easily understandable format for researchers in many varying disciplines by integrating and thereby simplifying concepts not usually discussed across a broad r
出版日期Book 2003
版次1
doihttps://doi.org/10.1385/1592594042
isbn_softcover978-1-4899-3828-2
isbn_ebook978-1-59259-404-7Series ISSN 1557-2153 Series E-ISSN 1940-6053
issn_series 1557-2153
copyrightSpringer Science+Business Media New York 2003
The information of publication is updating

書目名稱Cardiac Drug Development Guide影響因子(影響力)




書目名稱Cardiac Drug Development Guide影響因子(影響力)學(xué)科排名




書目名稱Cardiac Drug Development Guide網(wǎng)絡(luò)公開度




書目名稱Cardiac Drug Development Guide網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Cardiac Drug Development Guide被引頻次




書目名稱Cardiac Drug Development Guide被引頻次學(xué)科排名




書目名稱Cardiac Drug Development Guide年度引用




書目名稱Cardiac Drug Development Guide年度引用學(xué)科排名




書目名稱Cardiac Drug Development Guide讀者反饋




書目名稱Cardiac Drug Development Guide讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:51:31 | 只看該作者
J. Brindley,A. V. Holden,A. PalmerMAPKs found in cardiac tissue include the extracellular signal-regulated kinases (ERKs), the stress-activated/c-Jun NH2-terminal kinases (SAPK/JNKs), p38-MAPK, and ERK5/big MAPK 1 (BMK1). The ERKs are strongly activated by mitogenic and growth factors and by physical stress, SAPK/JNKs and p38-MAPK c
板凳
發(fā)表于 2025-3-22 03:55:33 | 只看該作者
V. S. Letokhov,A. A. Makarov,E. A. Ryabov function, providing additional targets for drug development. However, clinical experience has shown that the therapeutic index for the existing potent platelet inhibitors is narrow, suggesting that new and novel approaches to impairing platelet function will be required.
地板
發(fā)表于 2025-3-22 06:23:10 | 只看該作者
V. S. Letokhov,A. A. Makarov,E. A. Ryabovdominance of NHE-1 in the myocardium is of some importance because pharmacological development of NHE inhibitors for cardiac therapeutics has concentrated specifically on those agents that are selective for NHE-1. These agents, as well as the earlier nonspecific amiloride derivatives have now been e
5#
發(fā)表于 2025-3-22 11:16:59 | 只看該作者
6#
發(fā)表于 2025-3-22 15:20:48 | 只看該作者
The Role of Cardiac Pacemaker Currents in Antiarrhythmic Drug Discoveryas been a subject of much puzzlement. By the 1970s, it was clear that to provide a slow depolarization, there must be a slow increase in net inward current, although it was not clear whether this came about as a consequence of the slow inactivation of an outward current (presumed to be a carried by
7#
發(fā)表于 2025-3-22 18:32:26 | 只看該作者
8#
發(fā)表于 2025-3-22 21:29:44 | 只看該作者
9#
發(fā)表于 2025-3-23 03:41:49 | 只看該作者
The Sodium-Hydrogen Exchange System in the Heartdominance of NHE-1 in the myocardium is of some importance because pharmacological development of NHE inhibitors for cardiac therapeutics has concentrated specifically on those agents that are selective for NHE-1. These agents, as well as the earlier nonspecific amiloride derivatives have now been e
10#
發(fā)表于 2025-3-23 08:26:35 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-15 02:11
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
新余市| 来宾市| 济宁市| 临漳县| 巫山县| 阿城市| 台中县| 吉安县| 临洮县| 自治县| 清水河县| 奎屯市| 秭归县| 杭锦后旗| 崇明县| 大新县| 志丹县| 仪征市| 沅陵县| 彰化市| 定西市| 安溪县| 原阳县| 从江县| 临夏市| 微博| 资兴市| 洞头县| 交口县| 米林县| 靖江市| 上栗县| 兴仁县| 石柱| 宣恩县| 玛沁县| 同德县| 尼玛县| 华宁县| 汉沽区| 尼玛县|